|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Itatani Y, Kawada K, Fujishita T, Kakizaki
F, Hirai H, Matsumoto T, Iwamoto M, Inamoto S, Hatano E, Hasegawa
S, et al: Loss of SMAD4 from colorectal cancer cells promotes CCL15
expression to recruit CCR1+ myeloid cells and facilitate
liver metastasis. Gastroenterology. 145:1064–1075.e11. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aghakhani A, Hamkar R, Ramezani A,
Bidari-Zerehpoosh F, Sabeti S, Ghavami N, Banifazl M, Rashidi N and
Eslamifar A: Lack of human papillomavirus DNA in colon
adenocarcinama and adenoma. J Cancer Res Ther. 10:531–534.
2014.PubMed/NCBI
|
|
4
|
Zhang Y, Lin C, Liao G, Liu S, Ding J,
Tang F, Wang Z, Liang X, Li B, Wei Y, et al: MicroRNA-506
suppresses tumor proliferation and metastasis in colon cancer by
directly targeting the oncogene EZH2. Oncotarget. 6:32586–32601.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen L, Wang J, Fu L, Zhang B, Zhang H and
Ye B: Prognostic significance of metastasis associated in colon
cancer 1 (MACC1) expression in patients with gallbladder cancer. J
Cancer Res Ther. 10:1052–1056. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Manjelievskaia J, Brown D, McGlynn KA,
Anderson W, Shriver CD and Zhu K: Chemotherapy use and survival
among young and middle-aged patients with colon cancer. JAMA Surg.
152:452–459. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nicoloso MS, Spizzo R, Shimizu M, Rossi S
and Calin GA: MicroRNAs-the micro steering wheel of tumour
metastases. Nature reviews. Cancer. 9:293–302. 2009.PubMed/NCBI
|
|
8
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schwarzenbach H: Clinical relevance of
circulating, cell-free and exosomal microRNAs in plasma and serum
of breast cancer patients. Oncol Res Treat. 40:423–429. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Alvarez-Díaz S, Valle N, Ferrer-Mayorga G,
Lombardía L, Herrera M, Domínguez O, Segura MF, Bonilla F, Hernando
E and Muñoz A: MicroRNA-22 is induced by vitamin D and contributes
to its antiproliferative, antimigratory and gene regulatory effects
in colon cancer cells. Hum Mol Genet. 21:2157–2165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cai SD, Chen JS, Xi ZW, Zhang LJ, Niu ML
and Gao ZY: MicroRNA-144 inhibits migration and proliferation in
rectal cancer by downregulating ROCK-1. Mol Med Rep. 12:7396–7402.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cottonham CL, Kaneko S and Xu L: miR-21
and miR-31 converge on TIAM1 to regulate migration and invasion of
colon carcinoma cells. J Biol Chem. 285:35293–302. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yi H, Geng L, Black A, Talmon G, Berim L
and Wang J: The miR-487b-3p/GRM3/TGFβ signaling axis is an
important regulator of colon cancer tumorigenesis. Oncogene.
36:3477–3489. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li X, Li Z, Zhu Y, Li Z, Yao L, Zhang L,
Yuan L, Shang Y, Liu J and Li C: miR-524-5p inhibits angiogenesis
through targeting WNK1 in colon cancer cells. Am J Physiol
Gastrointest Liver Physiol. 318:827–839. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mullany LE, Herrick JS, Sakoda LC,
Samowitz W, Stevens JR, Wolff RK and Slattery ML: miRNA involvement
in cell cycle regulation in colorectal cancer cases. Genes Cancer.
9:53–65. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang L, Guo R, Yuan Z, Shi H and Zhang D:
LncRNA HOTAIR regulates CCND1 and CCND2 expression by sponging
miR-206 in ovarian cancer. Cell Physiol Biochem. 49:1289–1303.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Douaiher J, Ravipati A, Grams B, Chowdhury
S, Alatise O and Are C: Colorectal cancer-global burden, trends,
and geographical variations. J Surg Oncol. 115:619–630. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pan Y, Zhang J, Fu H and Shen L: miR-144
functions as a tumor suppressor in breast cancer through inhibiting
ZEB1/2-mediated epithelial mesenchymal transition process. Onco
Targets Ther. 9:6247–6255. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Q, Xia HW, Ge XJ, Zhang YC, Tang QL
and Bi F: Serum miR-19a predicts resistance to FOLFOX chemotherapy
in advanced colorectal cancer cases. Asian Pac J Cancer Prev.
14:7421–7426. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ritchie W, Rasko JE and Flamant S:
MicroRNA target prediction and validation. Adv Exp Med Biolgy.
774:39–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aqeilan RI, Calin GA and Croce CM: miR-15a
and miR-16-1 in cancer: Discovery, function and future
perspectives. Cell Death Differ. 17:215–220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Orhan C, Bulut P, Dalay N, Ersen E and
Buyru N: Downregulation of TCEAL7 expression induces CCND1
expression in non-small cell lung cancer. Mol Biol Rep.
46:5251–5256. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen G, Hu M, Qu X, Wang K and Qu Y:
MicroRNA-584 directly targets CCND1 and inhibits cell proliferation
and invasion in pancreatic cancer. Mol Med Rep. 19:719–726.
2019.PubMed/NCBI
|
|
25
|
Dai J, Wei RJ, Li R, Feng JB, Yu YL and
Liu PS: A study of CCND1 with epithelial ovarian cancer cell
proliferation and apoptosis. Eur Rev Med Pharmacol Sci.
20:4230–4235. 2016.PubMed/NCBI
|
|
26
|
Hao CY, Zhao S, Zhang LL and Liu D: SNHG16
promotes the progression of osteoarthritis through activating
microRNA-93-5p/CCND1 axis. Eur Rev Med Pharmacol Sci. 23:9222–9229.
2019.PubMed/NCBI
|
|
27
|
Nie M, Wang Y, Yu Z, Li X, Deng Y, Wang Y,
Yang D, Li Q, Zeng X, Ju J, et al: AURKB promotes gastric cancer
progression via activation of CCND1 expression. Aging (Albany NY).
12:1304–1321. 2020. View Article : Google Scholar : PubMed/NCBI
|
